Floatz logo

Nevadistinel

Mild Dementia

AptinyxSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

43 Active assets in the Mild Dementia cohort.

Asset / SponsorPhaseRating
Risperdal
Hannover Medical School
Phase 4BBB
CITALOPRAM
Hannover Medical School
Phase 4BBB
Galantamine Hydrobromide
Janssen Pharmaceutica N.V., Belgium
Phase 3BB
Namenda
Zealand University Hospital
Phase 4BB
Cipralex
Ohio State University
Phase 4BB

View all 50 →

Same molecule, other indications

Nevadistinel is also rated in:

Lewy body dementiaDormant
CCC
Indicative ·
53 / 100
View asset →
cognitive disorderDormant
CCC
Indicative ·
51 / 100
View asset →
Parkinson diseaseDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →